跳至主要内容
临床试验/JPRN-UMIN000041193
JPRN-UMIN000041193已完成未知

Changes in the factors associated with the renal prognosis during 12 months before and after administration of luseogliflozin in patients with type 2 diabetes - Changes in the factors associated with the renal prognosis during 12 months before and after administration of luseogliflozin in patients with type 2 diabetes

Department of Diabetes, Metabolism and Kidney Disease,Edogawa Hospital0 个研究点目标入组 238 人开始时间: 2020年7月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
238

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Subjects with replacement from other SGLT2 inhibitors or GLP-1 receptor antagonists, those with observation period less than 12 months, those with change of diuretics or anti-hypertensive agents during the observation period and those with add-on of GLP-1 receptor antagonists during the observation period

研究者

发起方
Department of Diabetes, Metabolism and Kidney Disease,Edogawa Hospital

相似试验

Changes in the factors associated with the renal... | 临床试验